We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

74 hedge funds and large institutions have $75.8M invested in Marker Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

471% more call options, than puts

Call options by funds: $2.53M | Put options by funds: $443K

33% more capital invested

Capital invested by funds: $56.8M → $75.8M (+$19M)

0.07% more ownership

Funds ownership: 3.2% → 3.27% (+0.07%)

0% more funds holding

Funds holding: 74 → 74 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

32% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 25

Holders
74
Holders Change
–
Holders Change %
0%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
17
Reduced
25
Closed
16
Calls
$2.53M
Puts
$443K
Net Calls
+$2.09M
Net Calls Change
+$1.47M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.19M
2
Millennium Management
Millennium Management
New York
+$3.01M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.35M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.59M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.79M
2
KCM
Kennedy Capital Management
Missouri
-$3.18M
3
State Street
State Street
Massachusetts
-$1.01M
4
Northern Trust
Northern Trust
Illinois
-$580K
5
N
Nuveen
North Carolina
-$431K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$29.9M – – –
ACM
2
Aisling Capital Management
New York
$8.77M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$7.51M +$374K +14,222 +6%
Millennium Management
4
Millennium Management
New York
$3.81M +$3.01M +114,303 +516%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$3.78M +$3.19M +121,090 +843%
Two Sigma Investments
6
Two Sigma Investments
New York
$2.79M +$2.35M +89,113 +816%
Victory Capital Management
7
Victory Capital Management
Texas
$2.58M -$165K -6,279 -6%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$1.76M +$1.59M +60,379 +2,204%
KCM
9
Kennedy Capital Management
Missouri
$1.68M -$3.18M -120,818 -67%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.52M +$160K +6,082 +13%
ACM
11
ACT Capital Management
Pennsylvania
$1.17M +$1.11M +42,000 New
Renaissance Technologies
12
Renaissance Technologies
New York
$1.12M +$1.05M +39,990 New
Marshall Wace
13
Marshall Wace
United Kingdom
$915K +$863K +32,783 New
Citadel Advisors
14
Citadel Advisors
Florida
$817K +$293K +11,132 +61%
AAM
15
AR Asset Management
California
$781K +$737K +28,000 New
BlackRock
16
BlackRock
New York
$722K -$4.79M -181,749 -88%
State Street
17
State Street
Massachusetts
$538K -$1.01M -38,348 -67%
BCM
18
Bridgeway Capital Management
Texas
$453K -$76K -2,885 -15%
Creative Planning
19
Creative Planning
Kansas
$420K -$29K -1,100 -7%
E
20
Ergoteles
New York
$383K +$362K +13,740 New
Goldman Sachs
21
Goldman Sachs
New York
$380K +$293K +11,114 +443%
Northern Trust
22
Northern Trust
Illinois
$320K -$580K -22,037 -66%
VWM
23
Vigilare Wealth Management
Arizona
$308K -$45K -1,710 -13%
AA
24
ALPS Advisors
Colorado
$305K +$288K +10,934 New
BRWA
25
B. Riley Wealth Advisors
Florida
$231K +$217K +8,260 New
1
2 3 4

MRKR Hedge Fund Activity: Q2 2021 in Review

74 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2021, worth a combined $75.8M — up 33% from $56.8M a quarter earlier.

Fund positioning in MRKR was balanced in Q2 2021: 16 funds opened new positions, 16 closed out, 17 added to existing stakes and 25 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $3.19M. The largest seller was BlackRock, cutting an estimated $4.79M.

  • 74 institutional investors held Marker Therapeutics (MRKR) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $75.8M of Marker Therapeutics stock for Q2 2021, up 33% quarter-over-quarter.
  • 16 funds opened new Marker Therapeutics positions in Q2 2021 and 16 closed out, a net change of 0 holders.
  • The largest Marker Therapeutics buyer in Q2 2021 was Two Sigma Advisers, an estimated $3.19M added.
  • The largest Marker Therapeutics seller in Q2 2021 was BlackRock, an estimated $4.79M sold.

Based on aggregated 13F filings for Q2 2021.